Evaluation of the efficacy, safety, satisfaction and tolerability of treatment with diluted botulinum toxin A in comparison with intralesional triamcinolone in patients undergone PDL laser for Hypertrophic erythematous scars: A blinded randomized controlled clinical trial

Iran University of Medical Sciences0 个研究点目标入组 12 人开始时间: 待定最近更新: 2022年3月8日

适应症

试验速览

暂无简介。

•Patients over 18 years
•Patients with a confirmed diagnosis of hypertrophic erythematous scars of at least 3
•The size of the mentioned lesions should be at least 10 × 10 cm or have a length of at least 10 cm
•The patient is not pregnant or breast feeding
•The patient has not received any treatment for lesions such as laser, topical or injectable corticosteroids in the past two months
•The patient has no underlying diseases that lead to the healing process of the scar; Such as diabetes or weakened immune system
•The patient's cooperation in performing medical interventions and referring to all treatment sessions

•Occurrence of pregnancy during treatment or follow-up period
•The occurrence of allergies or any side effects to one of the therapeutic interventions that prevent further treatment
•Diagnosis of malignancy or systemic disease during treatment or follow-up period
•The appearance of bacterial or viral skin diseases during treatment or follow-up

发起方